|
To date, PHBF has granted more than $255,000 in pediatric brain cancer research. In 2016, PHBF funded the Methylation 850 machine for clinical testing that was developed because of the generosity of PHBF supporters. Dr. Maryam Fouladi, Director of The Cincinnati Children's Hospital Brain Tumor Center, indicated this is the nation’s first machine of its kind that will genetically classify brain tumors to personalize treatment strategies for both clinical care and research.
|
